Roberto Pinelli, MD, CEO and founder of the Switzerland Eye Research Institute, shares how operations at the facility have adapted to the growing coronavirus pandemic spreading across the globe.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.